Trending...
- Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 106
- Revenue Optics Announces the Appointment of Sonal Chowdhury as Senior Manager – Strategic Operations
- How California Convinces Buyers Not to Purchase New Cars — and How This Hurts Dealers
OXFORD, England and CLEVELAND, Sept. 10, 2025 ~ New York City - On Tuesday, September 9, 2025, Lord Cameron, former UK Prime Minister and Chair of the Oxford-Harrington Rare Disease Centre (OHC) Advisory Council, was a featured guest speaker at the Morgan Stanley Exchange 2025 conference. The conference, held in New York City, brought together leaders in philanthropy, healthcare, and innovation to explore bold ideas for addressing global challenges.
Lord Cameron joined Andy Saperstein, Co-President of Morgan Stanley, for an intimate dialogue entitled "A Conversation on Courage". The session delved into topics such as leadership and philanthropy and their shared commitment to advancing progress in rare disease research and treatment.
As Chair of the OHC Advisory Council, Lord Cameron leads international efforts to achieve the Centre's ambitious goal of delivering 40 new rare disease treatments by 2034. This mission is deeply personal for Lord Cameron as it is rooted in his family's own experience with rare disease. He also played a crucial role in founding Genomics England and the groundbreaking 100,000 Genomes Project.
In his speech at Exchange 2025, Lord Cameron expressed his dedication to this cause stating that "Of the causes I have advocated for, this one is personal." He went on to highlight the OHC's unique approach of bringing together academia, life sciences, philanthropy, and industry to provide hope for millions worldwide living with rare diseases.
More on Ohio Pen
Andy Saperstein also praised Lord Cameron's leadership at the OHC stating that "His [Lord Cameron] leadership highlights how collaboration across science, philanthropy and investment can transform the future for millions of patients worldwide." He also emphasized Morgan Stanley's belief in the power of courageous ideas and their partnership with Harrington Discovery Institute to drive new cures.
The Morgan Stanley Exchange conference aims to bridge funding gaps by convening leading institutions, funders and innovators. Lord Cameron's participation underscored the importance of investment, partnership, and the role of philanthropy in delivering new treatments for rare diseases.
The conference also featured a photo of Lord Cameron alongside Andy Saperstein and Melanie Schnoll Begun, Head of Family Office Resources Field Engagement and Philanthropy Management at Morgan Stanley. The photo captured the spirit of collaboration and determination to find solutions for rare diseases.
The OHC is a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio. Their mission is to create new medicines for rare diseases and provide hope for millions worldwide. With Lord Cameron's leadership and the support of institutions like Morgan Stanley, they are well on their way to achieving their goal of delivering 40 new treatments by 2034.
Lord Cameron joined Andy Saperstein, Co-President of Morgan Stanley, for an intimate dialogue entitled "A Conversation on Courage". The session delved into topics such as leadership and philanthropy and their shared commitment to advancing progress in rare disease research and treatment.
As Chair of the OHC Advisory Council, Lord Cameron leads international efforts to achieve the Centre's ambitious goal of delivering 40 new rare disease treatments by 2034. This mission is deeply personal for Lord Cameron as it is rooted in his family's own experience with rare disease. He also played a crucial role in founding Genomics England and the groundbreaking 100,000 Genomes Project.
In his speech at Exchange 2025, Lord Cameron expressed his dedication to this cause stating that "Of the causes I have advocated for, this one is personal." He went on to highlight the OHC's unique approach of bringing together academia, life sciences, philanthropy, and industry to provide hope for millions worldwide living with rare diseases.
More on Ohio Pen
- Q4 2025 Outlook: JGCMGS Unveils High-Frequency Infrastructure for Italian and Global Markets
- UK Financial Ltd Announces Full Ecosystem To Erc-3643 "SEC-Ready" Tokens For All UK Financial Ltd Tokenized Projects
- Pushing the Wave Series Launches Premium Hardback Editions of 2017–2022 and 2023 Volumes
- Eco Plumbers, Electricians, and HVAC Technicians Announce Special Offer: Save $39 Off Any Plumbing
- ZEELOOL 2025 Black Friday and Cyber Monday Big Deals
Andy Saperstein also praised Lord Cameron's leadership at the OHC stating that "His [Lord Cameron] leadership highlights how collaboration across science, philanthropy and investment can transform the future for millions of patients worldwide." He also emphasized Morgan Stanley's belief in the power of courageous ideas and their partnership with Harrington Discovery Institute to drive new cures.
The Morgan Stanley Exchange conference aims to bridge funding gaps by convening leading institutions, funders and innovators. Lord Cameron's participation underscored the importance of investment, partnership, and the role of philanthropy in delivering new treatments for rare diseases.
The conference also featured a photo of Lord Cameron alongside Andy Saperstein and Melanie Schnoll Begun, Head of Family Office Resources Field Engagement and Philanthropy Management at Morgan Stanley. The photo captured the spirit of collaboration and determination to find solutions for rare diseases.
The OHC is a partnership between the University of Oxford, UK and Harrington Discovery Institute at University Hospitals, Cleveland, Ohio. Their mission is to create new medicines for rare diseases and provide hope for millions worldwide. With Lord Cameron's leadership and the support of institutions like Morgan Stanley, they are well on their way to achieving their goal of delivering 40 new treatments by 2034.
Filed Under: Business
0 Comments
Latest on Ohio Pen
- Coming Up on Fox Business America's Leading Annuity Expert Carlton Cap Averil II Joins Tom Hegna on "Financial Freedom with Tom Hegna"
- NATCO Awarded U.S. Patent for Persimonal® – Breakthrough Innovation in Preparing Persimmon Leaf Extract
- Rio Bela Cosmetics Launches Inclusive Line of Organic Skincare Products
- Edessa School of Fashion™ and (DE-FI) Global INC™ Plan Dayton's First Fashion Design College
- The 7 Visibility Problems Costing Independent Hotels Thousands Every Month
- Remington College Cleveland Collects over 10,000 Books for Toys for Tots Literacy Campaign
- Viola's Babygirl's, LLC Proudly Announces Teri Tobin's Soulful New Christmas EP "Home For The Holidays"
- Stoxtel Introduces High-Throughput "Matrix" Engine to Address Mexico's Crypto Trading Volatility
- UK Financial Ltd Sets Listing Date With Catex Exchange For The Listing Of Mayacat The World's First Ever Gold Backed ERC 3643 "SEC Ready" Token
- Cyntexa Announces Updates to ChargeOn on Salesforce AppExchange
- Althea Gibson Honored as Final Release in U.S. Mint's American Women Quarters Program
- Lokal Media House Achieves Yelp Platinum Partner Status
- World's First AI-Native Industrial Facility is Under Construction by Carbon AMS with rhobot.ai
- $57 Billion U.S. Marine Industry Presents Major Growth Opportunity for Newly Public Off The Hook Yacht Sales, Inc. (N Y S E: OTH)
- Dr. Alexander Eastman Returns to Suburban Hospital to Deliver Keynote on Crisis Leadership
- Scoop Social Co.'s Mobile Dessert Truck Business Offer A Lifestyle Of Flavor, Fun, and Freedom
- Own 327 Acres of American Prime Real Estate with 2 Miles Waterfront Worth In Millions for Just $7 — Worldwide Raffle Launched
- Lakefront Acreage in Longwood's Ravensbrook Community Hits the Market
- Monika Balayan Elected Fellow of the Royal Society of Arts (FRSA)
- We're Winning: Historic Plunge in Overdose Deaths Marks Stunning Reversal in America's Drug Crisis